Your SlideShare is downloading. ×
Veterinary vaccines market studies
Veterinary vaccines market studies
Veterinary vaccines market studies
Veterinary vaccines market studies
Veterinary vaccines market studies
Veterinary vaccines market studies
Veterinary vaccines market studies
Veterinary vaccines market studies
Veterinary vaccines market studies
Upcoming SlideShare
Loading in...5
×

Thanks for flagging this SlideShare!

Oops! An error has occurred.

×
Saving this for later? Get the SlideShare app to save on your phone or tablet. Read anywhere, anytime – even offline.
Text the download link to your phone
Standard text messaging rates apply

Veterinary vaccines market studies

166

Published on

Veterinary Vaccines Market research report covers the Types of Veterinary Vaccines and the different Species for which Vaccines are present in the market. The Types of Veterinary Vaccines covered …

Veterinary Vaccines Market research report covers the Types of Veterinary Vaccines and the different Species for which Vaccines are present in the market. The Types of Veterinary Vaccines covered include Live Attenuated, Inactivated, Recombinant and Other (Conjugate Vaccines, DNA Vaccines, Toxoids etc). The Species include Bovine, Porcine, Poultry, Canine & Feline, Ovine & Caprine and Other (Equine, Fish, Wild Animals etc.). The study includes estimations and predictions for the total global Veterinary Vaccines market and also key regional markets including North America, Europe, Asia-Pacific Latin America, Middle East and Rest of World. Business profiles of 13 major companies are discussed in the report. The report serves as a guide to global Veterinary Vaccines industry, covering more than 240 companies that are engaged in the development and supply of Veterinary Vaccines. Compilation of Worldwide Patents and Research related to Veterinary Vaccines is also provided. Information related to recent product releases, product developments, partnerships, collaborations, and mergers and acquisitions is also covered in the report. Exclusive graphically illustrated exhibits (144) complement the text.

Published in: Health & Medicine
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
166
On Slideshare
0
From Embeds
0
Number of Embeds
2
Actions
Shares
0
Downloads
11
Comments
0
Likes
0
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
No notes for slide

Transcript

  • 1. RITMIR021: Veterinary Vaccines – A Market Insight Report, July 2013 © RI Technologies - www.researchimpact.com Sample Page - 1 VETERINARY VACCINES MARKET SIZE Scope of the Study Veterinary Vaccines report covers the Types of Veterinary Vaccines and the different Species for which Vaccines are present in the market. The Types of Veterinary Vaccines covered include Live Attenuated, Inactivated, Recombinant and Other (Conjugate Vaccines, DNA Vaccines, Toxoids etc). The Species include Bovine, Porcine, Poultry, Canine & Feline, Ovine & Caprine and Other (Equine, Fish, Wild Animals etc.). The study includes estimates and projections for the total global Veterinary Vaccines market and also key regional markets that include North America, Europe, Asia-Pacific Latin America, Middle East and Rest of World. Estimates and projections are illustrated graphically. Business profiles of 13 major companies are discussed in the report. The report serves as a guide to global Veterinary Vaccines industry, covering 248 companies that are engaged in the development and supply of Veterinary Vaccines. Information related to recent product releases, product developments, partnerships, collaborations, and mergers and acquisitions is also covered in the report. Veterinary Vaccines report is an ideal research tool providing strategic business intelligence to the animal biologics corporate sector. This report may help strategists, investors, laboratories, pharmaceutical companies, contract research organizations, biotechnology companies and drug approval authorities in –  Gauging Competitive Intelligence  Identifying Key Growth Areas and Opportunities  Understanding Geographic Relevance to Product  Knowing Regional Market Sizes and Growth Opportunities and Restraints  Keeping Tab on Emerging Technologies  Equity Analysis  Tapping New Markets Analytics and data presented in this report pertain to several parameters such as –  Global and Regional Market Sizes, Market Shares, Market Trends  Product (Global and Regional) Market Sizes, Market Shares, Market Trends  Technology Trends  Corporate Intelligence  Key Companies By Sales, Brands, Products  Consumer Behavioral Patterns  Other Strategic Business Affecting Data
  • 2. RITMIR021: Veterinary Vaccines – A Market Insight Report, July 2013 © RI Technologies - www.researchimpact.com Sample Page - 2 Research Methodology RI Technologies publishes business intelligence reports by going through a cycle of diligent research and analysis activity. Research is done using both online and offline resources. The study outline of this report is sketched on the following lines – global market analysis, regional market analysis, product segmentation, global and regional market analysis by product segment, market trends, M&A, R&D, competitive landscape, technology trends, and other key drivers. Current data helps in analyzing the future of the industry and is also helpful for doing market evaluations, and estimating the market size for the future. This report is uniquely researched and the methodology includes:  Need and Scope of Study  Product Definitions  Segmental Analysis  Regional Analysis  Exclusive Data Analytics  Corporate Intelligence  Feedback Right from concept to final compilation of this report, both primary and secondary research methods are applied. We have provided exclusive feedback forms/pre-release questionnaires for this report to use the information for authentication of our own findings. Secondary research includes government publications, investment research reports, web based surveys, website information of both companies and markets, and other offline resources such as print publications and CDs. Our compilation of easy to navigate PDF reports are essential value addition resources for leading and growing companies.
  • 3. RITMIR021: Veterinary Vaccines – A Market Insight Report, July 2013 © RI Technologies - www.researchimpact.com Sample Page - 3 II. REPORT SYNOPSIS Immunology Immunology is a broad branch of biomedical science that covers the study of all aspects of the immune system in all organisms. It deals with the physical, chemical and physiological characteristics of the components of the immune system in vitro, in situ, and in vivo. It has been proved that the infection occurs in the body only if the immune system is weak. Many infectious diseases affect the human body because of immune system disorders. So, Immunology plays a vital role in treating of harmful diseases and reducing the weakness of humans or animals. Immunology helps  in diagnosis of the disease  as a major criterion in identifying the abnormal changes that take place in vivo Immunity Immunity is a biological state wherein the body has the ability to withstand and fight against bodily disorders or the invasion of foreign bodies that may harm the body. The immune system may be both specific and nonspecific. Specific immunity is one that immunes the body against specific disorders that may from time to time affect the body. Specific immune components adopt themselves in such a way as to create pathogens that are equipped to fight against the specific medical condition. Nonspecific immunity is one that always keeps the body on alert against any unwarranted or unexpected disorder or foreign body invasion. Vaccine In general a vaccine can be defined as an immunity booster or an injection administered to offer resistance to certain types of specific diseases. The term vaccine comes from the Latin word "vacca" which means cow. This term is an extract from the word cowpox first used by Edward Jenner. Segmentation of Veterinary Vaccines Exhibit 1. Segmentation of Global Veterinary Vaccines by Type and by Species By Type By Species  Live Attenuated  Bovine  Inactivated  Porcine  Recombinant  Poultry  Other 1  Canine & Feline  Ovine & Caprine  Other 2 1. Includes Conjugate Vaccines, DNA Vaccines, Toxoids. 2. Includes Equines, Wild Animals, Fish and Other Pets. © RIT, 2013
  • 4. RITMIR021: Veterinary Vaccines – A Market Insight Report, July 2013 © RI Technologies - www.researchimpact.com Sample Page - 4 Global Market Analysis Global Market for Veterinary Vaccines was estimated at US$ XX.XX billion in 2012. Global Veterinary Vaccines market is projected to reach US$ XX.XX billion by 2020 growing at a CAGR of XX.XX % during the analysis period (2005-2020). Exhibit 2. Veterinary Vaccines – Global Value Market Estimations & Predictions (2005-2020) in US$ Million Year Value 2005 XX.XX 2006 XX.XX 2007 XX.XX 2008 XX.XX 2009 XX.XX 2010 XX.XX 2011 XX.XX 2012 XX.XX 2013 XX.XX 2014 XX.XX 2015 XX.XX 2016 XX.XX 2017 XX.XX 2018 XX.XX 2019 XX.XX 2020 XX.XX CAGR% XX.XX © RIT Figures, 2013 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 US$ Million
  • 5. RITMIR021: Veterinary Vaccines – A Market Insight Report, July 2013 © RI Technologies - www.researchimpact.com Sample Page - 5 III. MARKET DYNAMICS Market Trends Application of genomics and proteomics plays an important role in vaccinology and has resulted in developing new vaccines and also improving the efficiency of present vaccines. Subunit vaccines, recombinant vaccines, DNA vaccines and vectored vaccines are rapidly gaining scientific and public acceptance as the new generation of vaccines and are considered as alternatives to current conventional vaccines. Almost 2000 of the licensed vaccines in the US are killed or live attenuated bacteria or viruses. Development in molecular biology, immunology and genetics has enhanced the production of safer and more effective vaccines. It is also pivotal to formulate and deliver these vaccines appropriately to maximize its potential in pathogenesis and vaccinology. Research and Selective Breeding Immunological research in animal species and means of stimulation of immunity should be intensified greatly. This is made easier with the access to genome sequences of major species such as cattle, dogs, pigs etc. Research on adjuvants which are cable of stimulating innate immunity is also of major importance. The methods of vaccine administration are an important aspect in veterinary vaccinology, especially in the case of vaccines for wild and domestic animals. These animals are not only hosts to identified diseases, but also for potential diseases that have not been identified yet. Certain vaccines are meant only for the preservation of endangered species. Guidelines for Small-Animal Vaccines In January, 2008 the (World Small Animal Veterinary Association (WSAVA)has laid down some guidelines whose main principal is to ensure that each and every animal in the world is vaccinated so that the frequency of vaccination of human beings is reduced. The organization strives at the bare minimum to ensure the vaccination of dogs and cats. The reason for giving top priority to dogs and cats is that these are domestic animals that come into touch with human beings most often. The vaccination of these animals would prevent the spread of infectious diseases and would optimize the immunity against such diseases. The basic vaccinations recommended by WSAVA are canine adenovirus (CAV), canine parvovirus (CPV), canine distemper virus (CDV), feline calicivirus (FCV), feline herpesvirus (FHV), and feline parvovirus (FPV). Apart from these there are other medications that are suggested by the organization based on the local requirements. WSAVA also recommends for an annual checkup of the animals. Plant-Based Vaccines The United States Department of Agriculture (USDA) announced the first global regulatory sanction for generation of vaccines from plants. Dow AgroSciences was the benefactor of this sanction. The company
  • 6. RITMIR021: Veterinary Vaccines – A Market Insight Report, July 2013 © RI Technologies - www.researchimpact.com Sample Page - 6 aims to bring viruses such the WNV and avian influenza into its screen by 2010. Apart from these it might also cover bovine pneumonia and canine diabetes. The advantage of this technology in comparison to other technologies is that plant proteins are much stable and can be preserved much more easily. Further, environmental risk factors arising out of contamination are largely minimized since no animal components are used. In traditional technologies it is always very important to be on the lookout for animal diseases like bovine spongiform encephalopathy. The plant-based vaccine technology works by making plants the production centers of the requisite proteins to develop the vaccines. Thus, these plants become the veritable storehouses for vaccine antigens that include bacteria, viruses and parasites. Another great benefit of the technology is its cost-effectiveness as not much cost is involved in the raising of plants. However, scientists have to keep a watchful eye to allergies to these vaccines. The availability of vaccines in immersion, injection and oral forms now offers a wide range of options to suit production systems, the priority being effectiveness and safety of new solutions and their economic value. Biotechnology is technology based on biology, especially when used in agriculture, food science, and medicine. Immunotechnology is an important arm of biotechnology, constituting the industrial scale application of immunological procedures to produce vaccines, for mass immunisation to prevent prevalent diseases and/or producing immunological therapeutic agents to cure the afflicted. Chick embryos are designed specifically for production of vaccines. DNA Vaccines 'The vaccine revolution’ known as 'DNA vaccines' is used in protecting disease causing infection. This technique involves inserting of a specific part of pathogen DNA into a living host. The host produces cells that have the ability to make proteins produced by invading pathogens leading to response against the infection. Further advancements include genetic engineering applications to produce edible vaccines. For creating edible vaccines, the genetic material of a plant is changed that helps in synthesizing e.g. Fruit. This is useful for countries lacking storage facilities or staff to administer vaccines to its people. Vaccines with Individual Antigens are Purer Progression and Cause of veterinary diseases and bacterial components identified can be used as antigens which stimulate the immune response to protect the animals against relevant disease. Vaccines with individual antigens are purer than the existing vaccines (which are killed whole cell bacteria or cultured supernatants containing mixture of chemically inactivated toxins) as they generate an effective and more focused immune response.
  • 7. RITMIR021: Veterinary Vaccines – A Market Insight Report, July 2013 © RI Technologies - www.researchimpact.com Sample Page - 7 Global Market Analysis Analysis by Type Global Market for Live Attenuated, Veterinary Vaccines is the largest type with an estimated value of US$ XX.XX billion in 2012 and is projected to reach US$ XX.XX billion by 2020 growing at a CAGR of XX.XX %. Recombinant Vaccine is the fastest growing type with a CAGR of XX.XX % during the period 2005-2020. Exhibit 3. Veterinary Vaccines - Global Value Market Estimations & Predictions (2005-2020) by Type for Live Attenuated, Inactivated, Recombinant and Other in US$ Million Year /Type Live Attenuated Inactivated Recombinant Other Total 2005 XX.XX XX.XX XX.XX XX.XX XX.XX 2006 XX.XX XX.XX XX.XX XX.XX XX.XX 2007 XX.XX XX.XX XX.XX XX.XX XX.XX 2008 XX.XX XX.XX XX.XX XX.XX XX.XX 2009 XX.XX XX.XX XX.XX XX.XX XX.XX 2010 XX.XX XX.XX XX.XX XX.XX XX.XX 2011 XX.XX XX.XX XX.XX XX.XX XX.XX 2012 XX.XX XX.XX XX.XX XX.XX XX.XX 2013 XX.XX XX.XX XX.XX XX.XX XX.XX 2014 XX.XX XX.XX XX.XX XX.XX XX.XX 2015 XX.XX XX.XX XX.XX XX.XX XX.XX 2016 XX.XX XX.XX XX.XX XX.XX XX.XX 2017 XX.XX XX.XX XX.XX XX.XX XX.XX 2018 XX.XX XX.XX XX.XX XX.XX XX.XX 2019 XX.XX XX.XX XX.XX XX.XX XX.XX 2020 XX.XX XX.XX XX.XX XX.XX XX.XX CAGR% XX.XX XX.XX XX.XX XX.XX XX.XX © RIT Figures, 2013 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 US$ Million Live Attenuated Inactivated Recombinant Other
  • 8. RITMIR021: Veterinary Vaccines – A Market Insight Report, July 2013 © RI Technologies - www.researchimpact.com Sample Page - 8 IV. PRODUCT TECHNOLOGY/RESEARCH Exhibit 4. Animal, Disease, Causative Agent, Name of Vaccine and Type of Vaccine Animal Disease Causative Agent Name of Vaccine Type of Vaccine Cattle and Buffalo Haemorrhagic Septicaemia P. multocida Type B:2 Haemorrhagic Septicaemia Double Adjuvant Vaccine Killed Vaccine Cattle and Buffalo Haemorrhagic Septicaemia P. multocida Type B:2 Haemorrhagic Septicaemia Alum Precipitated Vaccine Killed Vaccine Cattle and Buffalo Salmonellosis S. dublin and S. typhimurium Salmonella Double Adjuvant Vaccine Killed Oil Adjuvant Vaccine Ducks Pasteurellosis P. multocida and R. anatipestifer Duck Pasteurellosis Alum Precipitate Vaccine Killed Vaccine Chicken Fowl Cholera P. multocida Type A Fowl Cholera Alum Precipitated Vaccine Alum Precipitated Vaccine Chicken Infectious coryza H. paragallinarum Types A and C Alum Precipitate Inactivated Infectious Coryza Vaccine Alum Precipitated Inactivated Vaccine Chicken Newcastle Disease or Pseudo-fowl Pest Newcastle Disease Virus Newcastle Disease Vaccine ( Modified Live Virus Vaccine, Strain A) Freeze Dried Live Virus Vaccine Chicken Newcastle Disease Newcastle Disease Virus Newcastle Disease Vaccine ( Modified Live Virus Vaccine, Strain M) Freeze-Dried Vaccine Live Virus Vaccine Chicken Fowl pox Avipoxvirus. Fowl Pox Vaccine (Live Virus Vaccine Beaudette Strain) Lyopholised Live Vaccine Broilers and Layers Infectious Bronchitis Coronavirus Infectious Bronchitis (Uremic) Vaccine, (Modified Live Virus, Malaysian strain) Live Virus Vaccine Chicks Infectious Bursal Disease Infectious Bursal Disease Virus Infectious Bursal Disease Vaccine (Modified Live Virus, Malaysian strain) Live Lypholised Intermediate IBD Vaccine Ducks Duck Virus Enteritis (DVE) or Duck Plague Duck Herpes Virus 1 Duck Virus Enteritis Vaccine (Modified Live Virus, Malaysian strain) Lyopholised Live Attenuated Sheep and Goats Pasteurellosis P. multocida and P. haemolytica Sheep / Goat Pasteurellosis Alum Precipitate Vaccine Alum Precipitated Killed Vaccine © RIT, 2013 About RI Technologies RI Technologies is a premier source of market research on the Biotechnology & Healthcare sector. We emphasize on factual insights and forecasts with maximum global coverage. RI Technologies is constantly monitoring the biotechnology & Healthcare industry, tracking market trends, and forecasting industry
  • 9. RITMIR021: Veterinary Vaccines – A Market Insight Report, July 2013 © RI Technologies - www.researchimpact.com Sample Page - 9 based on specialized analysis. The life sciences sector is an ever growing marketplace with emerging technologies in areas of discovery, design and development. Research – As Good as the Methodology is!  Gauging Competitive Intelligence  Identifying Key Growth Areas and Opportunities  Understanding Geographic Relevance to Product  Knowing Regional Market Sizes and Growth Opportunities and Restraints  Keeping Tab on Emerging Technologies  Equity Analysis  Tapping New Markets © COPYRIGHT The copyright and publication rights to all RI Technologies' reports and other products are the property of the company. Plagiarism of any kind accounts to violation of copyright laws. Any type of reproduction of the material without express permission is not allowed. The buyer, under no circumstances, shall license, resell or repackage, or sell data without prior permission of the company. DISCLAIMER RI Technologies sells content in good faith. The company is not liable to the buyer for any implications arising out of the usage of data for any particular purpose. The company makes no representations or warranties for the accuracy or completeness of the data. While extreme caution and effort is practiced for data compilation and presentation, the company does not accept any responsibility for findings in the study which are a cumulative effort of primary and secondary research resources. The studies do not endorse or promote any product or company. RI Technologies, its affiliates, partners, distributors, and contractors are not liable for inaccuracies or incompleteness of the reports. User discretion is recommended for the usage of the data.

×